Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

40,863 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways.
Kim D, Rath O, Kolch W, Cho KH. Kim D, et al. Oncogene. 2007 Jul 5;26(31):4571-9. doi: 10.1038/sj.onc.1210230. Epub 2007 Jan 22. Oncogene. 2007. PMID: 17237813
BAX inhibitor-1 enhances cancer metastasis by altering glucose metabolism and activating the sodium-hydrogen exchanger: the alteration of mitochondrial function.
Lee GH, Yan C, Shin SJ, Hong SC, Ahn T, Moon A, Park SJ, Lee YC, Yoo WH, Kim HT, Kim DS, Chae SW, Kim HR, Chae HJ. Lee GH, et al. Among authors: kim ds, kim hr, kim ht. Oncogene. 2010 Apr 8;29(14):2130-41. doi: 10.1038/onc.2009.491. Epub 2010 Feb 1. Oncogene. 2010. PMID: 20118983
Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking.
Kim DS, Choi YB, Han BG, Park SY, Jeon Y, Kim DH, Ahn ER, Shin JE, Lee BI, Lee H, Hong KM, Kim SY. Kim DS, et al. Among authors: kim dh, kim sy. Oncogene. 2011 Dec 1;30(48):4780-90. doi: 10.1038/onc.2011.183. Epub 2011 May 30. Oncogene. 2011. PMID: 21625219
Smad3 regulates E-cadherin via miRNA-200 pathway.
Ahn SM, Cha JY, Kim J, Kim D, Trang HT, Kim YM, Cho YH, Park D, Hong S. Ahn SM, et al. Among authors: kim ym, kim d, kim j. Oncogene. 2012 Jun 21;31(25):3051-9. doi: 10.1038/onc.2011.484. Epub 2011 Oct 24. Oncogene. 2012. PMID: 22020340
PERK inhibits DNA replication during the Unfolded Protein Response via Claspin and Chk1.
Cabrera E, Hernández-Pérez S, Koundrioukoff S, Debatisse M, Kim D, Smolka MB, Freire R, Gillespie DA. Cabrera E, et al. Among authors: kim d. Oncogene. 2017 Feb 2;36(5):678-686. doi: 10.1038/onc.2016.239. Epub 2016 Jul 4. Oncogene. 2017. PMID: 27375025
Foxp3 is a key downstream regulator of p53-mediated cellular senescence.
Kim JE, Shin JS, Moon JH, Hong SW, Jung DJ, Kim JH, Hwang IY, Shin YJ, Gong EY, Lee DH, Kim SM, Lee EY, Kim YS, Kim D, Hur D, Kim TW, Kim KP, Jin DH, Lee WJ. Kim JE, et al. Among authors: kim tw, kim d, kim kp, kim sm, kim ys, kim jh. Oncogene. 2017 Jan 12;36(2):219-230. doi: 10.1038/onc.2016.193. Epub 2016 May 30. Oncogene. 2017. PMID: 27238838
IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.
Guo J, Kim D, Gao J, Kurtyka C, Chen H, Yu C, Wu D, Mittal A, Beg AA, Chellappan SP, Haura EB, Cheng JQ. Guo J, et al. Among authors: kim d. Oncogene. 2013 Jan 10;32(2):151-9. doi: 10.1038/onc.2012.39. Epub 2012 Feb 13. Oncogene. 2013. PMID: 22330135 Free PMC article.
Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis.
Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M, Gallagher GT, Varvares M, Cohen D, Kim D, Kent R, Donoff RB, Todd R, Yung CM, Warrington JA, Wong DT. Alevizos I, et al. Among authors: kim d. Oncogene. 2001 Sep 27;20(43):6196-204. doi: 10.1038/sj.onc.1204685. Oncogene. 2001. PMID: 11593428
Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population.
Fukunaga-Kalabis M, Martinez G, Nguyen TK, Kim D, Santiago-Walker A, Roesch A, Herlyn M. Fukunaga-Kalabis M, et al. Among authors: kim d. Oncogene. 2010 Nov 18;29(46):6115-24. doi: 10.1038/onc.2010.350. Epub 2010 Aug 23. Oncogene. 2010. PMID: 20729912 Free PMC article.
A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment.
Lucas PC, Kuffa P, Gu S, Kohrt D, Kim DS, Siu K, Jin X, Swenson J, McAllister-Lucas LM. Lucas PC, et al. Among authors: kim ds. Oncogene. 2007 Aug 16;26(38):5643-54. doi: 10.1038/sj.onc.1210342. Epub 2007 Mar 5. Oncogene. 2007. PMID: 17334391
40,863 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback